中华皮肤科杂志 ›› 2017, Vol. 50 ›› Issue (1): 29-32.

• 论著 • 上一篇    下一篇

丹参酮ⅡA体外促进黑素瘤A375细胞自噬及信号通路的实验研究

李小静1,李志锋2,李显平3,刘保国2,刘志军4   

  1. 1. 河北邯郸 河北工程大学附属医院
    2. 河北工程大学附属医院
    3. 河北邯郸 河北工程大学附属医院皮肤科
    4.
  • 收稿日期:2016-05-03 修回日期:2016-09-04 出版日期:2017-01-15 发布日期:2017-01-05
  • 通讯作者: 刘保国 E-mail:lbg66@163.com

In vitro effects of tanshinone ⅡA on autophagy of A375 melanoma cells and related signaling pathway

xiao-jing 1, 1, 1, 1   

  • Received:2016-05-03 Revised:2016-09-04 Online:2017-01-15 Published:2017-01-05

摘要: 目的 探讨丹参酮ⅡA体外对黑素瘤细胞A375细胞自噬的影响及其信号通路研究。方法 0.5、1、2、4 mg/L丹参酮ⅡA作用黑素瘤A375细胞24、48、72 h后,噻唑蓝(MTT)比色法检测A375细胞的增殖活性。1、2、4 mg/L丹参酮ⅡA作用黑素瘤A375细胞48 h,采用流式细胞仪检测细胞自噬小体的数量,Western印迹检测自噬相关蛋白Beclin?1和微管相关蛋白1轻链3(LC3)?Ⅱ蛋白及磷酸肌醇3激酶(PI3K)、蛋白激酶B(Akt)、雷帕霉素靶蛋白(mTOR)、p70S6激酶1(p70S6K1)蛋白的表达水平。结果 MTT分析显示,0.5、1、2和4 mg/L丹参酮ⅡA分别作用黑素瘤A375细胞24、48、72 h,均能抑制A375细胞的增殖能力,且抑制作用呈剂量和时间依赖性(F = 2 564.12、1 235.25,均P < 0.05)。流式细胞仪显示,1、2和4 mg/L丹参酮ⅡA作用A375细胞48 h后,细胞内自噬小体比例分别为6.91% ± 0.35%、13.11% ± 0.73%、25.51% ± 0.83%,均明显高于对照组(0.41% ± 0.02%),各组间差异有统计学意义(均P < 0.05)。Western印迹显示,1、2和4 mg/L丹参酮ⅡA作用A375细胞48 h后,细胞自噬相关蛋白Beclin?1和LC3?Ⅱ表达水平随丹参酮ⅡA浓度增加而升高,各丹参酮ⅡA组间差异有统计学意义,且高于对照组(均P < 0.05)。而PI3K?Akt?mTOR?p70S6K1信号通路中PI3K、p?Akt、 p?mTOR和p?p70S6K1蛋白表达随丹参酮ⅡA浓度增加而下降,各丹参酮ⅡA组间差异有统计学意义,且低于对照组(均P < 0.05)。结论 丹参酮ⅡA可通过抑制P13K?Akt?mTOR?p70S6K1信号通路,促进黑素瘤细胞发生自噬。

Abstract: Li Xiaojing, Li Zhifeng, Li Xianping, Liu Baoguo, Liu Zhijun Department of Dermatology, Affiliated Hospital of Hebei University of Engineering, Handan 056002, Hebei, China Corresponding authors: Liu Baoguo, Email: LBG66@163.com; Liu Zhijun, Email: zlmdsh@126.com 【Abstract】 Objective To investigate in vitro effects of tanshinone ⅡA on the autophagy of A375 melanoma cells and related signaling pathway. Methods Some cultured A375 cells were divided into 5 groups to be treated with tanshinone ⅡA at concentrations of 0.5, 1, 2 and 4 mg/L, and DMEM containing 0.1% dimethyl sulfoxide (DMSO), respectively, for 24, 48, 72 hours. Methyl thiazol tetrazolium (MTT) assay was performed to estimate the proliferative activity of A375 cells. Some cultured A375 cells were divided into 4 groups to be treated with 1, 2 and 4 mg/L tanshinone ⅡA (1-, 2- and 4-mg/L tanshinone group), and DMEM containing 0.1% DMSO (control group), respectively, for 48 hours. Then, flow cytometry was conducted to count autophagosome-positive cells, and Western blot analysis to determine protein of autophagy-associated proteins Beclin-1, microtubule-associated protein 1 light chain 3 (LC3) -Ⅱ, phosphatidylinositol 3-kinase (PI3K), protein kinase B (Akt), mammalian target of rapamycin (mTOR) and p70 ribosomal protein S6 kinase 1 (p70S6K1). Results MTT assay showed that 24-, 48-, 72-hour treatments with tanshinone ⅡA at concentrations of 0.5, 1, 2 and 4 mg/L all could inhibit the proliferative activity of A375 cells, and the inhibitory effects increased in a dose- and time-dependent manner (F = 2 564.12, 1 235.25, both P < 0.05). The percentage of autophagosome-positive cells and protein of Beclin-1 and LC3-Ⅱ increased gradually and significantly in the 1-, 2- and 4-mg/L tanshinone groups (autophagosome-positive cells: 6.91% ± 0.35%, 13.11% ± 0.73%, 25.51% ± 0.83%, respectively; Beclin-1: 0.33 ± 0.01, 0.53 ± 0.04, 0.63 ± 0.02, respectively; LC3-Ⅱ: 0.41 ± 0.01, 0.52 ± 0.02, 0.64 ± 0.02, respectively), after 48-hour treatment, which were significantly different between the tanshinone groups (all P < 0.05), and higher in the tanshinone groups than in the control group (0.41% ± 0.02%; 0.09 ± 0.02; 0.21 ± 0.01, all P < 0.05). However, the protein of PI3K, phosphorylated Akt (p-Akt), p-mTOR and p-p70S6K1 in the PI3K-Akt-mTOR-p70S6K1 signaling pathway decreased gradually and significantly with the increase in tanshinone concentrations after 48-hour treatment, and were significantly lower in all the tanshinone groups than in the control group (all P < 0.05). Conclusion Tanshinone ⅡA can promote the auophagy of A375 cells, likely by blocking the PI3K-Akt-mtTOR-p70S6K1 signaling pathway.